Abstract
A Phase IV, Multicenter, Open-Label Study of Emicizumab Prophylaxis in Persons with Hemophilia a with or without FVIII Inhibitors Undergoing Minor Surgical Procedures
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have